Category: Life Sciences Reports

This area includes the yearly life sciences and Biotech reports with statistics retrieved from Biotechgate.

Danish Life Sciences Trend Analysis 2016

More biotech companies have been founded after stagnation in the last 2 years. However, 2016 has been slow in private Biotech funding. Danish LS Trend Analysis 2016   Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more

Read more

German Life Sciences Trend Analysis 2016

2015 was a quiet year in terms of the emergence of new private German biotech companies but in terms of financing, the 12 months remained steady. That being said it was not enough to match the high of the latter half of 2014, where USD 247.5m was raised. Read the full report below. German LS … Continue reading German Life Sciences Trend Analysis 2016

Read more

Canadian Life Sciences Trend Analysis 2016

The amount of private Canadian biotech companies founded in 2015 was the lowest in at least 10 years, with just two new businesses entering the field. However private Biotech funding has enjoyed a small increase in total investment in H1 of 2016 when compared to the final months of last year. Download the full trend … Continue reading Canadian Life Sciences Trend Analysis 2016

Read more

Swiss Life Sciences Trend Analysis 2016

Our latest trend analysis of the Swiss biotechnology and life sciences sector shows that despite a slow start to the year, investment in the area rose substantially in the second half of 2015. However the decline in the amount of new biotech companies being founded has continued. In fact last year had the lowest number of … Continue reading Swiss Life Sciences Trend Analysis 2016

Read more

Spanish Life Sciences Trend Analysis 2016

The second half of 2015 was hugely successful in terms of private investment in Spanish biotech companies, both in Catalonia and throughout Spain as a whole. Companies raised USD 86.6m in H2 of last year, compared to USD 5.6m in the six months previously. You can download our full trend analysis below. Spanish LS Trend … Continue reading Spanish Life Sciences Trend Analysis 2016

Read more

Danish Life Sciences Trend Analysis 2015

The Danish venture financing remained stable from 2013 to 2015 at around USD 85m. However, private financing of Biotech companies showed a large intercompany variation. Danish LS Trend Analysis 2015   Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more

Read more

Sweden Life Sciences Trend Analysis 2015

After the best venture financing of Swedish Biotechnology Company of the last 5 years in 2014, the venture financing goes back to previous level in 2015 to date. The pipeline is maturing and renewing at the same time, with the number of products in phase II similar to the number of product in preclinical studies. … Continue reading Sweden Life Sciences Trend Analysis 2015

Read more

German Life Sciences Trend Analysis 2015

Venture financing of German biotechnology companies drop to normal levels in 2015 following the best year for venture financing in the last 5 years. In the first half of 2015, close to USD 90m was raised in 5 financing rounds. German LS Trend Analysis 2015   Looking for your next Biotech or Medtech partner? Use … Continue reading German Life Sciences Trend Analysis 2015

Read more